iProtics | Valuation, Funding Rounds & Stock Price | Caplight
iProtics
Private
Leiden Healthcare & Life Sciences https://iprotics.eu/
Last Round
Seed
Oct 10, 2024
Total Funding Raised
$850,000
Company Overview
iProtics is a biotechnology company developing selective immunoproteasome inhibitors to treat hematological cancers and autoimmune disorders.
Sector Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
immunoproteasome inhibitor, peptide-based therapy, drug discovery, hematological cancer, autoimmune disorder, biotech startup, pre-clinical development, targeted therapy, oncology research, biotech spin-out, proteasome inhibitor, precision medicine, drug pipeline, biopharma
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unlock Pricing Charts
Caplight Momentum Score
Proprietary index based on bid/ask volume and sentiment.
View Momentum History
iProtics Comparables
Compare iProtics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IpiNovyx Bio | 87% | Unlock |
| QLi5 Therapeutics GmbH | 82% | Unlock |
| Aurinia Pharmaceuticals Inc. | 76% | Unlock |
| Comparable company | 50% | Unlock |
iProtics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 10, 2024 | Unlock | Unlock | Unlock | Unlock |
| Grant | Mar 20, 2024 | Unlock | Unlock | Unlock | Unlock |
| Accelerator | Sep 9, 2022 | Unlock | Unlock | Unlock | Unlock |
Key People
Elmer Maurits
CEO Co-founder
LinkedIn profile
iProtics Investors
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Seed |
| Netherlands Organization for Scientific Research | Grant |
| Life Sciences @ Work Venture Challenge | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
Oct 10, 2024
$380K round led by uniiq
Mar 20, 2024
$220K grant from Netherlands Organization for Scientific Research.
iProtics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iProtics's valuation, stock price, and market status.
- Is iProtics a public or private company?
- What is the current stock price of iProtics?
- How much is iProtics worth (valuation)?
- Can I buy iProtics stock?
- When was iProtics's last funding round?
- Who are the main investors in iProtics?
- Will iProtics IPO soon?
- How can I track iProtics secondary market activity?
Firmographic Details
Headquarters Leiden
Employee Range 2
Year Founded 2024
Last Funding Oct 10, 2024